Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase I/Ib Trial of Radiotherapy in Combination With Durvalumab (MEDI4736) Prior to Surgical Resection for HPV Negative Squamous Cell Carcinoma of the Head and Neck (HNSCC)

Next Previous
Trial Profile

Phase I/Ib Trial of Radiotherapy in Combination With Durvalumab (MEDI4736) Prior to Surgical Resection for HPV Negative Squamous Cell Carcinoma of the Head and Neck (HNSCC)

Recruiting
Phase of Trial: Phase I

Latest Information Update: 20 Dec 2018

At a glance

  • Drugs Durvalumab (Primary)
  • Indications Head and neck cancer; Squamous cell cancer
  • Focus Adverse reactions

    • Most Recent Events

    • 02 Nov 2018 Status changed from not yet recruiting to recruiting.
    • 09 Oct 2018 Planned initiation date changed from 1 Sep 2018 to 1 Dec 2018.
    • 24 Aug 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Legal

Back to top